Terms: = Germ cell tumor AND MYD88, Q99836, MYD88D, 4615 AND Prognosis
7 results:
1. SESN1 functions as a new tumor suppressor gene via Toll-like receptor signaling pathway in neuroblastoma.
Hua Z; Chen B; Gong B; Lin M; Ma Y; Li Z
CNS Neurosci Ther; 2024 Mar; 30(3):e14664. PubMed ID: 38516781
[TBL] [Abstract] [Full Text] [Related]
2. CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
Mallardo D; Fordellone M; White A; Ottaviano M; Sparano F; Bailey M; Facchini AB; Ong S; Maiolino P; Caracò C; Church S; Cavalcanti E; Warren S; Budillon A; Cesano A; Simeone E; Chiodini P; Ascierto PA
J Transl Med; 2023 Sep; 21(1):610. PubMed ID: 37684649
[TBL] [Abstract] [Full Text] [Related]
3. A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma.
Zhang J; Du J; Jin Z; Qian J; Xu J
PeerJ; 2023; 11():e15615. PubMed ID: 37456890
[TBL] [Abstract] [Full Text] [Related]
4. Upregulated Immunogenic cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor prognosis in High-Grade Gliomas.
Tang X; Guo D; Yang X; Chen R; Jiang Q; Zeng Z; Li Y; Li Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429083
[No Abstract] [Full Text] [Related]
5. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
[TBL] [Abstract] [Full Text] [Related]
6. Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7.
Zhang R; Li P; Lv H; Li N; Ren S; Xu W
Stem Cell Res Ther; 2021 Jun; 12(1):349. PubMed ID: 34134771
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.
Wang W; Zhao Z; Wu F; Wang H; Wang J; Lan Q; Zhao J
J Neurooncol; 2018 Feb; 136(3):495-503. PubMed ID: 29168084
[TBL] [Abstract] [Full Text] [Related]
